Physician profile
Robert C Tomaro
NPI 1972586162
$1,829.73
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360 · 2020: $27.65 · 2021: $344 · 2022: $400 · 2023: $523 · 2024: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $685 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.91 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $502.80 | 2019-2023 | Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $274.89 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $121.40 | 2023-2024 | Myfembree |
| Evofem Biosciences, INC. | $112.59 | 2021-2024 | Phexxi |
| Innovation Technologies INC | $107.01 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $104.98 | 2019-2023 | |
| Hologic Sales and Service, LLC | $94.56 | 2019 | |
| Astellas Pharma US INC | $77.61 | 2019-2024 | Veozah |
| Agile Therapeutics, INC. | $61.89 | 2021-2023 | Twirla |
| Pfizer INC. | $43.73 | 2019-2023 | |
| Lupin INC. | $43.13 | 2019 | |
| Exeltis, USA INC. | $41.12 | 2019-2023 | Slynd |
| Millicent US INC | $34.88 | 2023 | Intrarosa, Femring |
| Therapeuticsmd, INC. | $29.87 | 2021-2022 | |
| Myovant Sciences INC. | $29.52 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $28.44 | 2022-2023 | Nexplanon |
| Daiichi Sankyo INC. | $21.54 | 2024 | Injectafer |
| Shield Therapeutics INC | $18.24 | 2023 | Accrufer |
| Smith+Nephew, INC. | $16.00 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.93 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.91 | 2019 | |
| Avion Pharmaceuticals | $13.18 | 2021 | |
| Coopersurgical, INC. | $11.91 | 2019 | |
| Allergan, INC. | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Tomaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.